Clinical trial
Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
NCT00496613 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00496613 |
|---|---|
| Title | Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors |
| Official title | Chemotherapy-Induced Cognitive Change and DNA Damage in Breast Cancer Survivors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer, Long-Term Survivors |
| Intervention type | Behavioral |
| Interventions | Mini-Mental State Exam and Blood draw, Mini-Mental State Exam and Blood Draw |
| Enrollment | 200 |
| Start date | Jun 1, 2007 |
| Primary completion | Apr 18, 2022 |
| Completion | Apr 18, 2022 |
| First posted | Jul 4, 2007 |
| Last update posted | Apr 21, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: